- Home
- GHRS vs NXRT Comparison
GHRS vs NXRT Comparison
Compare GHRS & NXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHRS
- NXRT
- Stock Information
- Founded
- GHRS 2018
- NXRT 2014
- Country
- GHRS Ireland
- NXRT United States
- Employees
- GHRS N/A
- NXRT N/A
- Industry
- GHRS Biotechnology: Pharmaceutical Preparations
- NXRT Real Estate Investment Trusts
- Sector
- GHRS Health Care
- NXRT Real Estate
- Exchange
- GHRS Nasdaq
- NXRT Nasdaq
- Market Cap
- GHRS 849.8M
- NXRT 860.7M
- IPO Year
- GHRS 2021
- NXRT N/A
- Fundamental
- Price
- GHRS $12.06
- NXRT $33.02
- Analyst Decision
- GHRS Strong Buy
- NXRT Hold
- Analyst Count
- GHRS 8
- NXRT 6
- Target Price
- GHRS $30.63
- NXRT $41.88
- AVG Volume (30 Days)
- GHRS 176.0K
- NXRT 182.3K
- Earning Date
- GHRS 05-08-2025
- NXRT 07-29-2025
- Dividend Yield
- GHRS N/A
- NXRT 6.15%
- EPS Growth
- GHRS N/A
- NXRT N/A
- EPS
- GHRS N/A
- NXRT N/A
- Revenue
- GHRS N/A
- NXRT $255,529,000.00
- Revenue This Year
- GHRS N/A
- NXRT N/A
- Revenue Next Year
- GHRS N/A
- NXRT $5.35
- P/E Ratio
- GHRS N/A
- NXRT N/A
- Revenue Growth
- GHRS N/A
- NXRT N/A
- 52 Week Low
- GHRS $6.00
- NXRT $30.98
- 52 Week High
- GHRS $20.50
- NXRT $48.37
- Technical
- Relative Strength Index (RSI)
- GHRS 52.59
- NXRT 41.47
- Support Level
- GHRS $11.50
- NXRT $32.45
- Resistance Level
- GHRS $12.94
- NXRT $34.27
- Average True Range (ATR)
- GHRS 0.98
- NXRT 0.73
- MACD
- GHRS -0.14
- NXRT 0.01
- Stochastic Oscillator
- GHRS 32.73
- NXRT 27.08
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About NXRT NexPoint Residential Trust Inc.
NexPoint Residential Trust Inc is a real estate investment trust company. Its objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. The company seeks to achieve these objectives through targeted management and a capex value-add program. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.